Novavax begins trial of the Phase 3 COVID vaccine with plans to enroll 30,000 volunteers in the US and Mexico
Myovant shares rise 16% in the premarket with news of Pfizer’s cancer drug business worth up to $ 4.2 billion
‘Gee, I’m a $ TSLA-naire!’ Here’s how quickly Tesla’s wild ride transformed modest investments into unexpected seven-digit gains
